Literature DB >> 26838581

Rate of recurrence and malignant transformation in 88 cases with inverted papilloma between 1998-2008.

Alexander Nygren1, Katalin Kiss2, Christian von Buchwald1, Anders Bilde1.   

Abstract

Conclusions The recurrence rate of IP in the current study is comparable to international and national studies. When the primary tumour was located in the frontal or the sphenoid sinus, the tumour seemed more likely to recur. Some recurrences were more than 2 years after primary surgery, suggesting continued need for long-term follow-up. The rate of malignant transformation in inverted papilloma cases has not changed in Denmark. Objectives Inverted papillomas are benign tumours located in the nasal cavity and paranasal sinuses. They are known for their tendency to recur after surgery and show invasive growth, causing bone remodulation and the association with malignant transformation. The introduction of endoscopic sinus surgery and computer aided sinus surgery over the last decades has made this tumour more approachable with less cosmetic and functional damage. The objective of this study is to establish whether the recurrence rate and the rate of malignant transformation of IP have changed with the application of these new techniques. Method A retrospective study between 1998-2008 including 88 cases with inverted papilloma. Results In total, 25.3% had recurrence. Combined surgical approach with endoscope/open approach had the lowest rate of recurrence. A malignant transformation in the postoperative histological examination was found in 8.9%.

Entities:  

Keywords:  Papilloma; computer-assisted; inverted; paranasal sinus neoplasms; recurrence; schneiderian; surgery

Mesh:

Year:  2016        PMID: 26838581     DOI: 10.3109/00016489.2015.1116123

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  7 in total

1.  Morphologic, intraoperative, and histologic risk factors for sinonasal inverted papilloma recurrence.

Authors:  Jake J Lee; Lauren T Roland; Jordan J Licata; Hilary L P Orlowski; Pawina Jiramongkolchai; Jay F Piccirillo; Dorina Kallogjeri; Cristine N Klatt-Cromwell; Rebecca D Chernock; John S Schneider
Journal:  Laryngoscope       Date:  2019-05-21       Impact factor: 3.325

Review 2.  Risk Factors of Recurrence and Malignant Transformation of Sinonasal Inverted Papilloma.

Authors:  Marta Gamrot-Wrzoł; Paweł Sowa; Grażyna Lisowska; Wojciech Ścierski; Maciej Misiołek
Journal:  Biomed Res Int       Date:  2017-11-09       Impact factor: 3.411

3.  Frontal inverted papillomas: A 25-year study.

Authors:  Cheuk Lun Sham; C Andrew van Hasselt; Samuel M W Chow; Dennis L Y Lee; Ryan H W Cho; John K S Woo; Michael C F Tong
Journal:  Laryngoscope       Date:  2019-08-16       Impact factor: 3.325

4.  Origin site-based staging system of sinonasal inverted papilloma for application to endoscopic sinus surgery.

Authors:  Yifan Meng; Gaoli Fang; Xiangdong Wang; Xiaohong Song; Kuiji Wang; Hongfei Lou; Wenyu She; Long Qin; Mei Lv; Tao Zhang; Tiejun Yuan; Yanli Tao; Xun Meng; Luo Zhang; Chengshuo Wang
Journal:  Head Neck       Date:  2018-12-15       Impact factor: 3.147

5.  Computed Tomography as a Predictor of Sinonasal Inverted Papilloma Origin, Skull Base Involvement, and Stage.

Authors:  Jake J Lee; Hilary L P Orlowski; John S Schneider; Lauren T Roland; Rami Eldaya; Pawina Jiramongkolchai; Dorina Kallogjeri; Rebecca D Chernock; Cristine N Klatt-Cromwell
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-20

6.  Sinonasal inverted papilloma: rate of recurrence and malignant transformation in 44 operated patients.

Authors:  Mariana Ferreira Sbrana; Renata Ferraz Rafael Borges; Fábio de Rezende Pinna; Deusdedit Brandão Neto; Richard Louis Voegels
Journal:  Braz J Otorhinolaryngol       Date:  2019-08-12

7.  Does evaluation of tumor volume or/both origination site better guide to optimal surgery for inverted papilloma?

Authors:  Muammer Melih Şahin; Metin Yılmaz; Mehmet Ekrem Zorlu; Mehmet Göcek; Mehmet Düzlü; Erolcan Sayar; Alper Ceylan
Journal:  Braz J Otorhinolaryngol       Date:  2019-11-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.